 WES MOORE, Governor  Ch. 706  
 
– 1 – Chapter 706  
(House Bill 1087 ) 
 
AN ACT concerning  
 
Health Insurance – Step Therapy or Fail –First Protocols – Drugs to Treat 
Associated Conditions of Advanced Metastatic Cancer  
 
FOR the purpose of prohibiting certain insurers, nonprofit health service plans, and health 
maintenance organizations from imposing a step therapy or fail –first protocol on 
certain prescription drugs used  prescribed by a treating physician  to treat a 
sympt om of or a side effect from treatment of certain metastatic cancer under certain 
circumstances; and generally relating to step therapy and fail –first protocols and 
health insurance.  
 
BY repealing and reenacting, without amendments,  
 Article – Insurance  
Section 15 –142(a)(1) and (4) and (b)  
 Annotated Code of Maryland  
 (2017 Replacement Volume and 2024 Supplement)  
 
BY repealing and reenacting, with amendments,  
 Article – Insurance  
Section 15 –142(e)  
 Annotated Code of Maryland  
 (2017 Replacement Volume and 2024 Supplement)  
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 
That the Laws of Maryland read as follows:  
 
Article – Insurance  
 
15–142. 
 
 (a) (1) In this section the following words have the meanings indicated.  
 
  (4) (i) “Step therapy or  fail–first protocol” means a protocol established 
by an insurer, a nonprofit health service plan, or a health maintenance organization that 
requires a prescription drug or sequence of prescription drugs to be used by an insured or 
an enrollee before a pre scription drug ordered by a prescriber for the insured or the enrollee 
is covered.  
 
   (ii) “Step therapy or fail –first protocol” includes a protocol that 
meets the definition under subparagraph (i) of this paragraph regardless of the name, label, 
or termi nology used by the insurer, nonprofit health service plan, or health maintenance 
organization to identify the protocol.  
Ch. 706  2025 LAWS OF MARYLAND   
 
– 2 –  
 (b) (1) This section applies to:  
 
   (i) insurers and nonprofit health service plans that provide hospital, 
medical, or surgical benefits to individuals or groups on an expense –incurred basis under 
health insurance policies or contracts that are issued or delivered in the State; and  
 
   (ii) health maintenance organizations that provide hospital, 
medical, or surgical benefits to ind ividuals or groups under contracts that are issued or 
delivered in the State.  
 
  (2) An insurer, a nonprofit health service plan, or a health maintenance 
organization that provides coverage for prescription drugs through a pharmacy benefits 
manager is subj ect to the requirements of this section.  
 
 (e) An entity subject to this section may not impose a step therapy or fail –first 
protocol on an insured or an enrollee for a prescription drug approved by the U.S. Food and 
Drug Administration if:  
 
  (1) (I) the prescription drug is used to treat the insured’s or enrollee’s 
stage four advanced metastatic cancer; and  
 
  [(2)] (II) use of the prescription drug is:  
 
   [(i)] 1. consistent with the U.S. Food and Drug  
Administration –approved indication or the National  Comprehensive Cancer Network 
Drugs & Biologics Compendium indication for the treatment of stage four advanced 
metastatic cancer; and  
 
   [(ii)] 2. supported by peer –reviewed medical literature ; OR 
 
  (2) (I) THE PRESCRIPTION DRU G IS USED  PRESCRIBED BY A 
TREATING PHYSICIAN  TO TREAT A SYMPTOM O F OR A SIDE EFFECT F ROM 
TREATMENT OF THE INS URED’S OR ENROLLEE ’S STAGE FOUR ADVANCE D 
METASTATIC CANCER THAT THE TREATING PR OVIDER  DETERMINES WILL 
NEGATIVELY IMPACT TH E INSURED ’S OR ENROLLEE ’S HEALTH IF  LEFT UNTREATED ; 
AND  
 
   (II) USE OF THE PRESCRIPT ION DRUG IS : 
 
    1. CONSISTENT WITH BEST  PRACTICES FOR THE 
TREATMENT OF STAGE F OUR ADVANCED METASTA TIC CANCER , A CONDITION 
ASSOCIATED WITH STAG E FOUR ADVANCED META STATIC CANCER , OR A SIDE EFFECT 
ASSOCIATED WITH STAG E FOUR  ADVANCED METASTATIC CANCER TREATMENT ; AND 
 
 WES MOORE, Governor  Ch. 706  
 
– 3 –     2. SUPPORTED BY PEER –REVIEWED MEDICAL 
LITERATURE ; AND 
 
   (III) THE PRESCRIPTION DRU G IS COVERED UNDER T HE TERMS 
OF THE POLICY OR CON TRACT OF THE INSURED  OR ENROLLEE . 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall apply to all 
policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or 
after January 1, 2026.  
 
 SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 
January 1, 2026.  
 
Approved by the Governor, May 20, 2025.  